Streptococcal glycoprotein-induced tumour cell growth inhibition involves the modulation of a pertussis toxin-sensitive G protein

British Journal of Cancer

Volumn 73, Issue 8, 1996, Pages 917-923

  Yoshida, J ^a   Takamura, S ^a   Suzuki, S ^a   Nishio, M ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gi protein; Glycoprotein; Pertussis toxin; Streptococci; Tumour cell growth

Indexed keywords

GLYCOPROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL STRAIN L 929; FIBROSARCOMA; MOUSE; NONHUMAN; NUCLEIC ACID SYNTHESIS; PERTUSSIS; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; TUMOR GROWTH;

EID: 0029931888     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.182     Document Type: Article

References (32)

1. AGARWAL S, DRYSDALE B-E AND SHIN HS. (1988). Tumor necrosis factor-mediated cytotoxicity involves ADP-ribosylation. J. Immunol., 140, 4187-4192.
2. BIRNBAUMER L. (1992). Receptor-to-effector signaling through G proteins: Roles for βγ dimers as well as α subunits. Cell, 71, 1069-1072.
3. BIRNBAUMER L, ABRAMOWITZ J AND BROWN AM. (1990). Receptor-effector coupling by G proteins. Biochimi. Biophys. Acta., 1031, 163-224.
4. BOURNE HR, SANDERS DA AND MCCORMICK F. (1990). The GTPase superfamily: a conserved switch for diverse cell functions. Nature, 348, 125-132.
5. GILMAN AG. (1984). G proteins and dual control of adenylate cyclase. Cell, 36, 577-579.
6. GILMAN AG. (1987). G proteins: Transducers of receptor-generated signals. Annu. Rev. Biochem., 56, 615-649.
7. HEPBURN A, BOEYNAEMS J-M, FIERS W AND DUMONT JE. (1987). Modulation of tumor necrosis factor-α cytotoxicity in L929 cells by bacterial toxins, hydrocortisone and inhibitors of arachidonic acid metabolism. Biochem. Biophys. Res. Comm., 149, 815-822.
8. HEPLER JR AND GILMAN AG. (1992). G proteins. Trends. Biochem. Sci., 17, 383-387.
9. IMAMURA K, SHERMAN ML, SPRIGGS D AND KUFE D. (1988). Effect of tumor necrosis factor on GTP binding and GTPase activity in HL-60 and L929 cells. J. Biol. Chem., 263, 10247-10253.
10. KAHN RA AND GILMAN AG. (1984). ADP-ribosylation of Gs promotes the dissociation of its α and β subunits. J. Biol. Chem., 259, 6235-6240.
11. KANAOKA M, FUKITA Y, TAYA K, KAWANAKA C, NEGORO T AND AGUI H. (1987a). Antitumor activity of streptococcal acid glycoprotein produced by Streptococcus pyogenes, Su. Jpn. J. Cancer Res. (Gann), 78, 1409-1414.
12. KANAOKA M, KAWANAKA C, NEGOROT T, FUKITA Y AND TAYA K. (1987b). Cloning and expression of the antitumor gene of Streptococcus pyogenes Su in Escherichia coli. Agric. Biol. Chem., 51, 2641-2648.
13. KATADAT AND UI M. (1982). Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc. Natl Acad. Sci. USA., 79, 3129-3133.
14. KATADA T, OINUMA M AND UI M. (1986). Two guanine nucleotide-binding proteins in rat brain serving as the specific substrate of islet-activating protein, pertussis toxin. J. Biol. Chem., 261, 8182-8191.
15. + channel. Nature, 337, 555-557.
16. LAEMMLI UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
17. MURAYAMA T AND UI M. (1983). Loss of the inhibitory function of the guanine nucleotide regulatory component of adenylate cyclase due to its ADP ribosylation by islet-activating protein, pertussis toxin, in adipocyte membranes. J. Biol. Chem., 258, 3319-3326.
18. NAKAHATA N, ABE MT, MATSUOKA I, ONO T AND NAKANISHI H. (1991). Adenosine inhibits histamine-induced phosphinositide hydrolysis mediated via pertussis toxin-sensitive G protein in human astrocytoma cells. J. Neurochem., 57, 963-969.
19. NAUTS HC, SWIFT WE AND COLEY BL. (1946). The treatment of malignant tumor by bacterial toxins as developed by the late William B Coley, M.D., reviewed in the light of modern research. Cancer Res., 6, 205-216.
20. NEER EJ AND CLAPHAM DE. (1988). Roles of G protein subunits in transmembrane signalling. Nature, 333, 129-134.
21. NORTHUP JK, STERNWEIS PC, SMIGEL MD, SCHLEIFER LS, ROSS EM AND GILMAN AG. (1980). Purification of the regulatory component of adenylate cyclase. Proc. Natl Acad. Sci. USA., 77, 6516-6520.
22. OKAOMOTO H, SHOIN S AND KOSHIMURA S. (1978). Streptolysin s-forming and antitumor activities of group A streptococci. In Bacterial Toxins and Cell Membranes, Jeljaszewicz J and Wadström T. (eds) pp. 259-289. Academic Press: London.
23. OLD LJ. (1985). Tumor necrosis factor (TNF). Science, 230, 630-632.
24. REILLY HC. (1953). Microbiology and cancer therapy: a review. Cancer Res., 13, 821-834.
25. ROOK G. (1992). Tumours and Coley's toxins. Nature, 357, 545.
26. 2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res., 50, 7101-7107.
27. STARNES CO. (1992). Coley's toxins in perspective. Nature, 357, 11-12.
28. YOSHIDA J, YOSHIMURA M, TAKAMURA S AND KOBAYASHI S. (1985). Purification and characterisation of an antitumor principle from Streptococcus hemolyticus (Su strain). Jpn. J. Cancer Res., 76, 213-223.
29. YOSHIDA J, TAKAMURA S AND SUZUKI S. (1987). Cell growth-inhibitory action of SAGP, an antitumor glycoprotein from Streptococcus pyogenes (Su strain). Jpn. J. Pharmacol., 45, 143-147.
30. YOSHIDA J, TAKAMURA S AND SUZUKI S. (1989). A simplified method for purification of an antitumor acidic glycoprotein from Streptococcus pyogenes (Su strain) by immunoadsorbent chromatography. J. Antibiotics, 42, 448-453.
31. YOSHIDA J, TAKAMURA S AND SUZUKI S. (1991). Antitumor action of an acidic glycoprotein (SAGP) from Streptococcus pyogenes in mice. Biotherapy, 3, 331-336.
32. YOSHIDA J, TAKAMURA S AND SUZUKI S. (1994). Evidence for the involvement of sulfhydryl groups in the expression of antitumor activity of streptococcal acid glycoprotein (SAGP) purified from crude extract of Streptococcus pyogenes. Anticancer Res., 14, 1833-1838.